Biogen Idec (Biogen Idec) Biogen Idec is a global biotechnology company, a publicly traded company and a component of the NASDAQ 100 index, formed by the merger of Biogen (founded in 1978) and IDEC (founded in 1986) in 2003. Biogen Idec develops drugs for neurological diseases and cancer;